Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. It causes damage to the myelin sheath that protects nerve fibers and leads to impaired transmission of signals between the brain and other parts of the body. Common symptoms of MS include vision problems, muscle weakness, tingling or numbness, walking difficulties, fatigue and cognitive issues. The exact cause of MS is unknown but genetics and environment are believed to play a role in triggering the disease. While there is no cure for MS yet, various disease-modifying therapies are available to help reduce frequency and severity of relapses or progression of disability.
Multiple Sclerosis Therapeutics: First-line Disease-Modifying Therapies (DMTs)
The Multiple Sclerosis Therapeutics are usually one of the injectable or oral DMTs proven to be effective and generally safe. Interferon beta and glatiramer acetate were some of the earliest approved therapies. These work by modifying the body's immune response to delay progression.
Get More Insights On, Multiple Sclerosis Therapeutics
For More Insights Discover the Report In language that Resonates with you